Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers - A randomized controlled trial

被引:174
作者
MacDonald, NE
Halperin, SA
Law, BJ
Forrest, B
Danzig, LE
Granoff, DM
机构
[1] Univ Ottawa, Ottawa, ON, Canada
[2] Dalhousie Univ, Halifax, NS, Canada
[3] Univ Manitoba, Winnipeg, MB, Canada
[4] Chiron Corp, Chiron Vaccines, Emeryville, CA USA
[5] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1998年 / 280卷 / 19期
关键词
D O I
10.1001/jama.280.19.1685
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context.-Meningococcal polysaccharide vaccines are not used routinely in infants and toddlers, the groups at highest risk of invasive disease, because of poor immunologic responses to the Neisseria meningitidis serogroup C polysaccharide in these age groups. Meningococcal C conjugate vaccines offer the prospect of circumventing this problem. Objective.-To assess the immunogenicity and the induction of immunologic memory in toddlers by meningococcal C conjugate vaccine. Design.-A multicenter, randomized, observer-blinded controlled trial. Setting.-Urban and suburban family medicine or pediatric practices, Participants.-Two hundred eleven healthy toddlers aged 15 to 23 months. Intervention.-Two injections at 2 months apart of meningococcal C conjugate (group 1, n = 69), plain meningococcal polysaccharide (group 2, n = 72), or hepatitis B virus vaccine (group 3, n = 70). All toddlers received a follow-up dose of plain meningococcal polysaccharide vaccine 12 months later. Main Outcome Measures.-IgG meningococcal C anticapsular antibody concentrations determined by enzyme-linked immunosorbent assay and complement-mediated bactericidal antibody. Results.-In group 1, the magnitude of the IgG response to meningococcal C conjugate vaccine was more than 4-fold higher after dose 1 and more than 10-fold higher after dose 2 compared with meningococcal polysaccharide vaccine (group 2) (P<.001). Higher titers persisted in the meningococcal C conjugate group for at least 12 months (P<.001). Group 1, primed with meningococcal C conjugate, had 25-fold higher IgG responses to the meningococcal polysaccharide 1-year booster dose than the controls who had received hepatitis B virus vaccine initially and were given meningococcal polysaccharide vaccine 1 year later for the first time (P<.001). In contrast, group 2, primed with meningococcal polysaccharide, had a 2-fold lower response to the 1-year booster meningococcal polysaccharide dose than the hepatitis B virus control group (P=.006), Serum bactericidal responses paralleled the enzyme-linked immunosorbent assay responses. Conclusions.-Immunization of toddlers with meningococcal C conjugate vaccine induces high titers of anticapsular and bactericidal antibody. Furthermore, this vaccine induces immunologic memory to meningococcal C polysaccharide. In contrast, meningococcal polysaccharide vaccine is less immunogenic than the conjugate vaccine and also induces a hyporesponsive state that persists for at least 12 months.
引用
收藏
页码:1685 / 1689
页数:5
相关论文
共 23 条
[1]  
Amato Neto V, 1974, Rev Inst Med Trop Sao Paulo, V16, P149
[2]   Conjugate meningococcal serogroup A and C vaccine: Reactogenicity and immunogenicity in United Kingdom infants [J].
Fairley, CK ;
Begg, N ;
Borrow, R ;
Fox, AJ ;
Jones, DM ;
Cartwright, K .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (06) :1360-1363
[3]   IMMUNE-RESPONSE OF HUMAN INFANTS TO POLYSACCHARIDE VACCINES OF GROUP-A AND GROUP-C NEISSERIA-MENINGITIDIS [J].
GOLD, R ;
LEPOW, ML ;
GOLDSCHNEIDER, I ;
GOTSCHLICH, EC .
JOURNAL OF INFECTIOUS DISEASES, 1977, 136 :S31-S35
[4]   KINETICS OF ANTIBODY-PRODUCTION TO GROUP-A AND GROUP-C MENINGOCOCCAL POLYSACCHARIDE VACCINES ADMINISTERED DURING THE 1ST 6 YEARS OF LIFE - PROSPECTS FOR ROUTINE IMMUNIZATION OF INFANTS AND CHILDREN [J].
GOLD, R ;
LEPOW, ML ;
GOLDSCHNEIDER, I ;
DRAPER, TF ;
GOTSCHLICH, EC .
JOURNAL OF INFECTIOUS DISEASES, 1979, 140 (05) :690-697
[5]   HUMAN IMMUNITY TO MENINGOCOCCUS .I. ROLE OF HUMORAL ANTIBODIES [J].
GOLDSCHNEIDER, I ;
GOTSCHLICH, EC ;
ARTENSTEIN, MS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1969, 129 (06) :1307-+
[6]   IMMUNOGENICITY OF GROUP-A AND GROUP-C MENINGOCOCCAL POLYSACCHARIDES IN HUMAN INFANTS [J].
GOLDSCHNEIDER, I ;
LEPOW, ML ;
GOTSCHLICH, EC ;
MAUCK, FT ;
BACHL, F ;
RANDOLPH, M .
JOURNAL OF INFECTIOUS DISEASES, 1973, 128 (06) :769-776
[7]   Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination [J].
Granoff, DM ;
Gupta, RK ;
Belshe, RB ;
Anderson, EL .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (03) :870-874
[8]   A modified enzyme-linked immunosorbent assay for measurement of antibody responses to meningococcal C polysaccharide that correlate with bactericidal responses [J].
Granoff, DM ;
Maslanka, SE ;
Carlone, GM ;
Plikaytis, BD ;
Santos, GF ;
Mokatrin, A ;
Raff, HV .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1998, 5 (04) :479-485
[9]   ANTIBODY-RESPONSES TO THE CAPSULAR POLYSACCHARIDE OF NEISSERIA-MENINGITIDIS SEROGROUP-B IN PATIENTS WITH MENINGOCOCCAL DISEASE [J].
GRANOFF, DM ;
KELSEY, SK ;
BIJLMER, HA ;
VANALPHEN, L ;
DANKERT, J ;
MANDRELL, RE ;
AZMI, FH ;
SCHOLTEN, RJPM .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1995, 2 (05) :574-582
[10]   MF59 adjuvant enhances antibody responses of infant baboons immunized with Haemophilus influenzae type b and Neisseria meningitidis group C oligosaccharide-CRM197 conjugate vaccine [J].
Granoff, DM ;
McHugh, YE ;
Raff, HV ;
Mokatrin, AS ;
VanNest, GA .
INFECTION AND IMMUNITY, 1997, 65 (05) :1710-1715